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Abstract. Parental-to-Fl-hybrid liver tissue grafts in like-sex donor-recipient 
combinations survive indefinitely, although several F1 recipients demonstrate an 
immunological response to the parental graft. Female F1 recipients, particularly 
those carrying the H - 2  b haplotype, respond vigorously to male parental liver 
grafts. However F 1 female responses to male parental liver tissue grafts differ 
substantively from the responses of parental females to syngeneic male grafts. 
C3H male liver grafts are rejected vigorously by F, females as long as the F~ 
carries the H - 2  b haplotype. These findings support previous reports of strong 
immunological responses to C3H H-Y antigen in female F, and C3H.SW 
animals, a response which is absent in C3H females. Female F 1 hybrids carrying 
the H - 2  b haplotype do not reject grafts of B 10 or B6 male liver as rapidly as do 
B10 or B6 parental females. This reduced F,  response may be related to the 
formation of hybrid antigens and consequent alteration of the anti-H-Y 
response. Alternatively, cells that specifically suppress the anti-H-Y response 
may be present in F~ hybrids. Factors responsible for suppression appear to be 
controlled by non-MHC antigens, at least in (C3H × B6 or B10) F 1 hybrids. 
Introduction 
It is generally expected that syngeneic grafts (within an inbred strain) or grafts from 
either parental strain to an F1 hybrid of those strains will be permanently accepted. 
However, F t hybrid responses to parental antigens have been reported in diverse 
systems. Cudkowicz and Bennett (1971) have shown that F1 hybrid mice resist 
parental bone marrow grafts. Homozygous tumors grow better in syngeneic 
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recipients than in their F t hybrids (Hellstr6m 1964, Snell 1958). Eichwald and co- 
workers (1965) have demonstrated similar phenomena in parental-to-F t skin grafts. 
More recently Nakano and colleagues (1981) have shown that cytotoxic T 
lymphocytes against parental H-2 antigens may be generated in Ft hybrids. 
One exception to the rule of permanent survival of syngeneic grafts is the 
rejection of male grafts by females of the same strain due to the presence of the H-Y 
antigen on the donor tissue (reviewed by Gasser and Silvers 1972). Skin grafts from 
male mice to syngeneic recipient females are rejected when the animals carry the K 
end of the H-2  b haplotype, but not when H-2  b is totally absent (Gasser and Silvers 
1972). Parental male skin grafts to F1 females are also rejected when one of the 
parental strains is H-2  b. Immune response to the H-Y antigen would seem to be 
under the control of the major histocompatibility complex (MHC). 
Studies of survival of parental-to-F1 skin grafts indicate that qualitative or 
quantitative differences among strains exist in the expression of the H-Y antigen, 
which is controlled by a gene or genes residing on the Y chromosome. These 
differences may, in part, result from MHC effects (Silvers and Wachtel 1977). 
Recently, evidence has been reported for the existence of a second H-Y antigen 
controlled by an autosomal gene (Simpson et al. 1982). 
Our interest in the similarities and differences of graft rejection phenomena in 
tissues other than skin or lymphocytes has led to a study of liver-graft rejection over 
the H-Y barrier (DeMott-Friberg et al. 1979). We have found that the strongest 
anti-H-Y response to liver tissue grafted onto a kidney bed is controlled by the H-2  b 
haplotype. A weak immune response to H-Y is found in female mice of strains 
carrying H - 2  haplotypes other than H - 2  b. Strangely, a strong anti-H-Y response is 
found in the SJL (H-2 s) strain. 
Ft females sometimes evoke a strong immune response to male liver grafts from 
parental strains other than the H-2  b parent. Response to grafts from the H - 2  b parent 
may also be weaker than the response to grafts from the n o n - H - 2  b parent. 
Several factors may be acting in F~ hybrids to modify the response of female 
mice of the H-2  b haplotype to grafts of male liver. The responses observed in these 
studies may be controlled by H-Y antigenic variation, an immune response unique 
to F~ hybrids, formation of hybrid antigens, or interaction between T-cell 
populations carrying different alleles at different H-2  subregions. 
Material and Methods 
Mice. Mice of all inbred strains used in these experiments were obtained from the National Cancer 
Institute (NCI) except mice of the C3H.SW/Sn congenic strain, which were obtained from the Jackson 
Laboratory, Bar Harbor, Maine. C57BL/6 x C3H (B6C3F1) mice were obtained from NCI. All other F 1 
mice were bred in our mouse colony at the Ann Arbor VA Medical Center. 
Graftino procedure and criteria for evaluation. The routine grafting procedure has been fully described 
previously (Schultz et al. 1976). In brief, a small piece of liver taken from an anesthesized donor is placed 
on the etherized recipient's left kidney, which has been prepared by removing a shallow subcapsular slice. 
The recipient's abdominal incision is sutured and the mouse returned to the animal colony. Although one 
donor can provide liver for all grafts of a series, usually several donors are used to control for possible 
autogenous results. Ten replicates of most donor recipient pairs were studied. However, in some cases 
there were as few as six or as many as eleven identical grafts performed. 
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At predetermined time periods, the recipient mice are killed by cervical dislocation. Grafted kidneys 
are removed, fixed, trimmed, embedded, sectioned, and stained. Numerous sections of each grafted 
kidney are screened to locate the central area of the graft. Three slides containing sections from the most 
central areas of the graft are then evaluated independently by three persons. 
Criteria for evaluation. Slides from replicate animals and serial time periods are evaluated on different 
days. Slides are examined without knowledge of the donor/recipient combinations, time period, or 
experiment to minimize subjective interpretations. A graft is first evaluated for rejection or survival by 
the presence of hepatocytes. The state of immunological reactivity of the host to the graft is judged by the 
quantity and nature (nodular or scattered) of lymphocytic infiltration, the quantity and physical state of 
fibrovascular tissue repopulating the graft (young and active or old and collagenized), the distribution of 
hepatocytes (well-organized as in a syngeneic graft, active and proliferating, or scattered and 
degenerating) and the appearance of the scar (newly formed or mature). Technical failures of grafts in this 
system are minimal and are easily distinguished from rejected grafts since hemosiderin laden 
macrophages mark the graft site. Photomicrographs of various immunological grades of graft have been 
published previously (DeMott-Friberg et al. 1979, Schultz et al. 1978). 
The scoring system for evaluating graft-host interaction for minor loci (Schultz et al. 1978) was used. 
This system uses P to identify a proliferating graft with more than four layers of hepatocytes with or 
without cellular immunological activity, S to identify a syngeneic-like graft with 3-4 well-organized 
layers of hepatocytes with little or no cellular immunological activity, C-1 to identify a healthy graft with 
a few lymphocytes concentrated or in small nodules at the graft-bed interface, C-2 to identify a graft 
containing less healthy, poorly organized hepatocytes with a considerable number of lymphocytes 
scattered throughout the graft, C-3 to identify a graft containing degenerating, scattered hepatocytes, 
copious lymphocytic infiltrate and fibrovascular tissue, C-4 to identify a graft with lymphocytes present 
in large nodules and with only a few scattered degenerating hepatocytes in a young scar, C-5 to identify a 
graft consisting of fibrovascular tissue with some collagen (young scar), a variable number of 
lymphocytes present and no hepatocytes and C-6 to identify a graft with only a matured (contracted) scar 
from which most lymphocytes have receded. The ultimate fate of a graft identified as C-6 is 
indistinguishable from that of an acutely rejected graft such as that seen across an H-2 barrier. 
Statistical analysis. The question of whether the immunological grades of grafts in any two donor- 
recipient combination are identical was determined by a goodness-of-fit test modified from Mood 1950, 
by Dr. R. Curl, Department of Chemical Engineering, University of Michigan. The goodness-of-fit test 
for the r and s contingency tables (at the 100~ level of significance) is: 
i=1 j=~ O~zjN>Z 2 (r-1)  (s -1) ;  
where ~,f / j= N; f~ 
i j 
and s = 7 immunological grades, r = 2 donor-recipient combinations to be compared andfi.is the number 
of animals assigned a particular grade for a particular donor-recipient combination. "J 
Immunological grade differences are of high significance (p<.0l), moderate significance (.01 <p 
<.025) or low significance (.025<p<.1). If the probability of two samples coming from the same 
population is greater than 0.1, they are considered to be identical in immunological grades. 
Results 
T h e  m e a n  i m m u n o l o g i c a l  r e ac t i v i t i e s  of  r e c i p i e n t  f e m a l e - F a ' s - t o - p a r e n t a l - m a l e  
d o n o r  l iver  g ra f t s  a re  f o u n d  in  T a b l e  1. E a c h  of  t he se  m e a n s  r e p r e s e n t s  a w e i g h t e d  
ave rage .  P r o l i f e r a t i n g  g ra f t s  a re  g i v e n  a w e i g h t  of  - 3  a n d  fully r e j ec t ed  g ra f t s  a re  
g i v e n  a w e i g h t  of  + 3. E a c h  of  t he  r e m a i n i n g  g r a d e s  is g i v e n  a w h o l e  n u m b e r  
w e i g h t i n g  b e t w e e n  - 3  a n d  + 3 .  S ince  p ro l i f e ra t i f i g  g ra f t s  a re  p o s s i b l y  b e i n g  
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enhanced, they are represented by a grade at the lowest end of the scale. Syngeneic- 
like grafts are weighted - 2  since they show neither rejection nor enhancement. The 
increasing immunological activities rated C-1 to C-5/6 are weighted - 1 to + 3. The 
mean grade is calculated by multiplying the number of animals with a particular 
rating by the weight for that rating, totalling all of the products for a particular 
combination, and dividing by the total number of grafted animals. The mean grades 
for each donor-recipient combination (parental-to-F 1 liver grafts for male-to- 
female, female-to-female, male-to-male and female-to-male donors to recipients) are 
given in Table 1. 
Donor-recipient combinations significantly different in immunological grade 
are shown in Tables 2a, b, and c. All other combinations analyzed are not 
statistically different. 
Data in Table 2a compares results in graft combinations in which the F1 
recipients are identical but the donors differ. These differences are only significant in 
a few cases. In Table 2b data are given comparing results in graft combinations in 
which the donors are identical but the F1 recipients vary. In both Tables 2a and 2b 
the donor and recipient combinations compared are of the same sex, i. e., a male-to- 
female graft combination is compared with a male-to-female graft combination, 
eliminating sex differences. There are only a few significant differences when 
combinations are compared in which the donors are constant and the F1 recipients 
differ (Table 2b). 
When donors and recipients are the same but the sex combinations differ, many 
highly significant differences among donor-recipient combinations are found (see 
Table 2c). This is true for all donors studied, but the extent of significance of the 
grade difference between any two donor recipient comparisons is dependent on 
whether H-2  b is one of the H-2  alleles in the recipient, which parental strain is the 
Table 1. M e a n  immunolog ica l  reactivity of F l ' s  to parenta l  grafts 
F 1 recipient D o n o r  D o n o r  and  recipient sex 
~ ?4? ~ ~ 
B 10 x B6 B6 + 3.0* (9) t - 1.6 (10) - 2.3 (10) - 2.2 (9) 
B10 +2 .6  (9) - 1 . 7  (10) - 2 . 3  (8) - 2 . 1  (11) 
B 1 0 x C 3 H . S W  B10 +1 .3  (10) - 1 . 5  (10) - 2 . 6  (10) - 2 . 5  (10) 
C3H .S W  + 3.0 (10) - 2.0 (10) - 2.4 (10) - 1.5 (11) 
B6 x C 3 H  B6 - 0 . 1  (8) - 1 . 6  (8) N D  :~ - 1 . 3  (6) 
C3H +3 .0  (8) - 2 . 0  (6) N D  N D  
B 1 0 x  C3H BI0  +0 .4  (11) - 1 . 3  (9) - 2 . 6  (10) - 2 . 0  (11) 
C3H +2 .7  (11) - 0 . 1  (11) - 2 . 8  (11) - 0 . 5  (11) 
DBA/2  x B 1 0  B10 +0.1  (8) - 1 . 6  (10) - 2 . 8  (8) - 1 . 5  (11) 
DBA/2  - 0 . 1  (9) - 1 . 8  (8) - 2 . 8  (10) - 2 . 8  (10) 
C3H x DBA/2  C3H - 0 . 5  (9) - 1.3 (4) - 2 . 0  (10) - 1.9 (10) 
DBA/2  - 1 . 3  (11) - 2 . 2  (6) - 2 . 1  (10) - 2 . 0  (9) 
* Immuno log ica l  grade range  = - 3  to + 3, least reactivity to greatest  reactivity. 
t ( ) = N u m b e r  in group.  
* N D ,  No  data.  
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Comparing 
Level of significance 
High Medium Low 
a. Identical F 1 recipients; different strain, like sex donors 
B6c~--+(B6 x C3H)9 and C3Ho~-+(B6 x C3H)9 
B6c~--+(B6 x C3H)9 and B10c?--+(B 10 x C3H)9 
B10c?---+(B10 x C3H)9 and C3H~---~(B10 x C3H)9 
B109--+(B10 x C3H)9 and C3H%-~(B10 x C3H)9 
B10%-+(B10 x C3H)g and C3Hg---+(B10 x C3H)d 
b. F 1 like sex recipients differing in one parent; identical donors 
B10c~-+(B6 x B10)9 and B10c~--+(B10 x C3H)9 
B6c~--+(B6 x B10)9 and B6d--,(B6 x C3H)~ + 
B10c~--+(B6 x B10)~ and B10~--+(DBA/2 x B10)g 
C3Hd'--+(B10 x C3H)9 and C3Hd'--+(C3H x DBA/2)~ + 
C3Hd'---+(B6 x C3H)9 and C3Hd'-+(C3H x DBA/2)9 + 
B10c~--+(B10 x C3H.SW)9 and B10ff--+(B10 x C3H)9 
+ 
c. Donors of same strain, recipients of same s t r a i n -  
sex difference in donor, recipient or both 
B6d---,(B10 x B6)9 and B69--,(B10 x B6)~: + 
B6d'---,(B10 x B6)9 and B6c~--+(B10 x B6)c~ + 
BI03---+(B10 x B6)9 and B109--+(B10 x B6)9 + 
B10c~-+(B10 x B6)~ and B 10c~-~(B10 x B6)c~ + 
C3Hc~---+(B6 × C3H)9 and C3Hg---+(B6 x C3H)9 + 
B10d'-~(B10 x C3H)9 and B10%-~(B10 x C3H)9 + 
B10d<---+(B 10 x C3H)9 and B 10c~-+(B10 x C3H)~ + 
C3Hc~---,(B10 x C3H)9 and C3Hg---+(B10 x C3H)2 + 
C3H~--+(B10 x C3H)9 and C3Hd<---+(B10 x C3H)d + 
B 10d<---+(DBA/2 x B10)9 and B10d~--+(DBA/2 x B10)c~ 
DBA/2d--,(DBA/2 x B 10)9 and DBA/2d--+(DBA/2 x B 10)d + 
DBA/2d-~(DBA/2 x g10)9 and DBA/2%--+(DBA/2 x B10)<~ + 
C3H~-~(C3H × DBA/2)9 and C3Hc?---+(C3H x DBA/2)c~ 
B10d<---+(B10 x C3H.SW)(2 and B10d--~(B 10 x C3H.SW)d < + 
B10c~---*(B10 x C3H.SW)'~ and B10%-,(B10 x C3H.SW)c~ 
C3H.SWo~-+(B10 x C3H.SW)9 and C3H.SWg-+(B10 x C3H.SW)9 + 
C3H.SWc?--+(B10 x C3H.SW)9 and C3H.SWc~--+(B10 x C3H.SW)d + 
C3H.SWc~---+(B10 x C3H.SW)~ and C3H.SW%--+(B10 x C3H.SW)d ~ + 
C3Hg--+(B10 x C3H)9 and C3Hc~---+(B 10 x C3H)c~ + 
C3Hg--+(B10 x C3H)c~ and C3H~-~(B10 x C3H)c~ 
+ 
+ 
donor for the combination, and whether one of the groups being compared is a 
male-to-female graft. 
Discussion 
We had previously found (DeMott-Friberg et al. 1979) that male-to-female 
syngeneic liver-to-kidney grafts were rejected within 35 days in the B 10 (H-2 b) strain 
and 140 days in the B6 (H-2 b) strain. C3H (H-2 ~) and DBA/2 (H-2 a) male-to-female 
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grafts, while showing some degree of immunological reactivity 140 and 70 days after 
grafting, respectively , survived indefinitely. Skin-grafting studies in congenic lines 
and recombinants (Bailey and Hoste 1971, Gasser and Silvers 1971, Bailey 1971, 
Stimpfling and Reichert 1971) showed that the H-2 b haplotype carries immune 
response genes that confer ability to respond to the H-Y antigenic determinant. In 
other skin-graft studies, Silvers and Billingham (1967) reported that the variable 
survival of male skin grafts in females of different strains resulted from strain 
dependent differences in the recipient's immune response. However, skin-graft 
studies in F1 animals (Wachtel et al. 1973) indicated that the H-2 type of the donor 
affected expression of the H-Y antigen. 
In these studies of male-to-female liver grafts, both strain-dependent expression 
of H-Y and differences in immune response were noted. Degree of expression of H-Y 
is probably independent of the strain's H-2 haplotype and results from qualitative 
or quantitative differences in H-Y itself or in modifying genes not linked to H-2. 
Thus the H-2 haplotype of the cell presenting H-Y does not affect liver allograft 
survival in the same way that H-2-H-Y interaction has been shown to affect 
immune response in other immunological systems (reviewed by Simpson 1982). 
DeMott-Friberg and co-workers (1979) reported that C3H (H-2 k) male-to-female 
liver grafts were not rejected at 70 days after grafting, but C3H.SW (H-2 b) male-to- 
female grafts were rejected. Since both of these strains carry the same H-Y antigen 
but differ in H-2, the difference in survival of male-to-female liver grafts could be 
attributed either to interaction of H-2 and H-Y on donor liver cells or to differences 
in the immune response of recipients bearing the H-2 k and the H-2 b haplotypes. The 
present studies show that both (B6 x C3H) F1 and (B10 x C3H) F 1 females reject 
C3H male liver grafts and that C3H.SW male liver grafts are also rejected by (B10 
x C3H.SW) F1 females. These data indicate that strong H-Y antigens are expressed 
on both C3H and C3H.SW male liver but that the immune response to these 
antigens in H-2 k females differs from the response of H-2 b females or H-2k/H-2 b 
females. 
Responses to grafts of B6 and B 10 male liver in F~ female recipients differed from 
responses in B6 and B10 female recipients (Table 1). (B10xC3H) F 1 female 
recipients rejected B10 male grafts but less vigorously than either (B10 x B6) F~ 
female recipients (.025 < p < . l )  or B10 female recipients (DeMott-Friberg et al. 
1979). Also (B6 x C3H) F~ female recipients rejected their H-2 b parental male grafts 
much less vigorously than did (B10 x B6) F~ females (p < .01) or B6 female recipients 
(DeMott-Friberg et al. 1979). The response to the H-Y antigen of both B 10 and B6 
liver is altered by the presence in the recipient of either the H-2 k of the C3H parent or 
non-H-2 genes that modify the immune response and that are present in C3H. Since 
the response to B 10 male liver grafts in (B 10 x C3H.SW) F1 female recipients is less 
vigorous than the response found in B 10 female recipients, suppression of response 
to B10 liver in the (C3H or C3H.SW x B10) F~ is not due to genes of the H-2 
complex. The suppressive effect in these combinations must be due to modification 
of the immune response by non-H-2 genes. 
Although B6-male-to-B6-female grafts survived longer (140 days) than B10- 
male-to-B 10 female grafts (35 days) (Schultz et al. 1982), B6 male grafts were rejected 
as vigorously or slightly more vigorously than B10 male grafts by (B6 x B10) F 1 
female recipients. These data further support the hypothesis that there are immune 
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response genes not linked to H-2  that influence the survival time of a male-to-female 
liver graft. These genes are responsible for different immune responses to the H-Y 
antigen in B10 females, B6 females and (B10 x B6) F1 hybrid females. 
yon Boehmer and co-workers (1978) have hypothesized that the tissue type of 
the thymus in which T-cell subpopulations differentiate influences the response to 
the H-Y antigen. This hypothesis, which is based on CML data, is consistent with 
our in vivo data. The results shown here point to suppression in F 1 animals that 
could result from differentiation processes unique to the F1. These changes in extent 
of suppression may be translated into anti-H-Y response that differ from parental 
responses. Moreover, the genetic focus of immunocompetent cell alterations does 
not appear to reside in the MHC. 
(DBA/2 x B10) F~ females also show less immune reaction to grafts from B10 
male liver donors (Table 1) than do B10 females. In this case either non-/-/-2 
modifying genes of the DBA/2 (H-2 ~) female or a unique immune response to genes 
formed from the hybridization of I region genes of the H-2  ~ and H-2  b haplotypes 
may act to reduce the immune response to the B10 male liver graft. The absence or 
reduced expression of I b specificities Ia.8 and Ia.9 in the (][b X I k) F1 combination has 
recently been reported (Sandrin et al. 1981). LaFuse and co-workers (1980) have also 
reported the appearance of hybrid Ia specificities in F1 mice. These specificities arise 
from combinations between subunits coded for by the I A  and I E  regions of two 
different H - 2  haplotypes. The results of Wicker and Hildemann (1981) indicate that 
the presence of hybrid molecules in F~ recipients may enhance or reduce the 
immune response of F1 animals to synthetic antigens. Simpson and Gordon (1977) 
cite Ir  gene complementation as a possible explanation for anti-H-Y reactivity in 
vitro in F~ hybrids. 
Neither H-2  d or H-2  k females are responders to the H-Y antigen in the liver- 
grafting system used in these studies. Female H-2d /H-2  k animals are also 
unresponsive to male parental grafts since (C3H x DBA/2)F 1 females failed to react 
to male grafts (Table 1). Therefore combining the C3H and DBA/2 genomes into a 
single F~ does not cause any change in the anti-H-Y immune response found in the 
C3H or DBA/2 inbred strains. 
We conclude from these studies that the H-Y antigen, which is expressed on liver 
cells (DeMott-Friberg et al. 1979), evokes an immune response in Fa mice. It 
appears that the strengths or concentrations of H-Y, or both, differ on liver cells of 
different strains, with the H-Y immune potential of C3H > B 10 > DBA/2. Similar 
differential expression of H-Y has been described in skin and the thymus (Krfilov/t 
and D6mant 1976). Response to the H-Y is greatest in the H-2  b haplotype but this 
response may be modified by the concomitant presence in the recipient of the H-2  ~ 
or H-2  k nonresponder haplotype, or by non-H-2 genes of the C3H or DBA/2 strain. 
It is possible that hybrid immune response antigens are responsible for the 
alteration in response seen in some F~ hybrid mice. An alternate explanation for the 
finding that F 1 immune response to liver grafts differs from that of either parental is 
the difference in functional characteristics of the immunocompetent cell popu- 
lations of F~ hybrids and parentals. This variation may be due to the presence of 
nonparental receptor sites on immunocompetent cells or to the Fa thymic 
environment in which the cells have differentiated. 
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